These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16232220)

  • 1. Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis.
    Toossi Z; Mayanja-Kizza H; Baseke J; Peters P; Wu M; Abraha A; Aung H; Okwera A; Hirsch C; Arts E
    Clin Exp Immunol; 2005 Nov; 142(2):327-32. PubMed ID: 16232220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.
    Mayanja-Kizza H; Wajja A; Wu M; Peters P; Nalugwa G; Mubiru F; Aung H; Vanham G; Hirsch C; Whalen C; Ellner J; Toossi Z
    J Infect Dis; 2001 Jun; 183(12):1801-4. PubMed ID: 11372034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation.
    Toossi Z; Hirsch CS; Wu M; Mayanja-Kizza H; Baseke J; Thiel B
    Clin Exp Immunol; 2011 Mar; 163(3):333-8. PubMed ID: 21303360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
    Kawamura T; Bruse SE; Abraha A; Sugaya M; Hartley O; Offord RE; Arts EJ; Zimmerman PA; Blauvelt A
    J Virol; 2004 Jul; 78(14):7602-9. PubMed ID: 15220435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.
    Meng Q; Sayin I; Canaday DH; Mayanja-Kizza H; Baseke J; Toossi Z
    PLoS One; 2016; 11(11):e0166954. PubMed ID: 27870882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation.
    Toossi Z; Johnson JL; Kanost RA; Wu M; Luzze H; Peters P; Okwera A; Joloba M; Mugyenyi P; Mugerwa RD; Aung H; Ellner JJ; Hirsch CS
    J Acquir Immune Defic Syndr; 2001 Sep; 28(1):1-8. PubMed ID: 11579270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis.
    Mayanja-Kizza H; Wu M; Aung H; Liu S; Luzze H; Hirsch C; Toossi Z
    Scand J Immunol; 2009 Jun; 69(6):516-20. PubMed ID: 19439012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.
    Mosier DE; Picchio GR; Gulizia RJ; Sabbe R; Poignard P; Picard L; Offord RE; Thompson DA; Wilken J
    J Virol; 1999 May; 73(5):3544-50. PubMed ID: 10196243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
    Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
    J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
    Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry.
    Cotter RL; Zheng J; Che M; Niemann D; Liu Y; He J; Thomas E; Gendelman HE
    J Virol; 2001 May; 75(9):4308-20. PubMed ID: 11287580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime.
    Toossi Z; Wu M; Hirsch CS; Mayanja-Kizza H; Baseke J; Aung H; Canaday DH; Fujinaga K
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):182-7. PubMed ID: 21453127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Productive HIV-1 infection is enriched in CD4(-)CD8(-) double negative (DN) T cells at pleural sites of dual infection with HIV and Mycobacterium tuberculosis.
    Meng Q; Canaday DH; McDonald DJ; Mayanja-Kizza H; Baseke J; Toossi Z
    Arch Virol; 2016 Jan; 161(1):181-7. PubMed ID: 26497177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short communication: Influence of active tuberculosis on chemokine and chemokine receptor expression in HIV-infected persons.
    Hanna LE; Bose JC; Nayak K; Subramanyam S; Swaminathan S
    AIDS Res Hum Retroviruses; 2005 Dec; 21(12):997-1002. PubMed ID: 16379602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.
    Collins KR; Quiñones-Mateu ME; Wu M; Luzze H; Johnson JL; Hirsch C; Toossi Z; Arts EJ
    J Virol; 2002 Feb; 76(4):1697-706. PubMed ID: 11799165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2.
    Ylisastigui L; Amzazi S; Bakri Y; Vizzavona J; Vita C; Gluckman JC; Benjouad A
    Biomed Pharmacother; 1998; 52(10):447-53. PubMed ID: 9921414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages.
    Hoshino Y; Tse DB; Rochford G; Prabhakar S; Hoshino S; Chitkara N; Kuwabara K; Ching E; Raju B; Gold JA; Borkowsky W; Rom WN; Pine R; Weiden M
    J Immunol; 2004 May; 172(10):6251-8. PubMed ID: 15128813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion and productive HIV-1 infection of Foxp3 positive CD4 T cells at pleural sites of HIV/TB co-infection.
    Hirsch CS; Baseke J; Kafuluma JL; Nserko M; Mayanja-Kizza H; Toossi Z
    J Clin Exp Immunol; 2016; 1(1):. PubMed ID: 28124031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
    Marozsan AJ; Torre VS; Johnson M; Ball SC; Cross JV; Templeton DJ; Quiñones-Mateu ME; Offord RE; Arts EJ
    J Virol; 2001 Sep; 75(18):8624-38. PubMed ID: 11507208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.